Exfoliative glaucoma and primary open-angle glaucoma: Associations with death causes and comorbidity

Acta Ophthalmologica Scandinavica

Volumn 82, Issue 4, 2004, Pages 401-404

  Ritland, Jon Ståle ^a   Egge, K ^b   Lydersen, S ^c   Juul, R ^c   Semb, S O ^b  

^a Alesund Hospital   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

Comorbidity; Death cause; Exfoliative glaucoma; Primary open angle glaucoma

Indexed keywords

ACETAZOLAMIDE;

ARTICLE; BRAIN ATROPHY; BRAIN DISEASE; CANCER; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; CHRONIC BRAIN DISEASE; COMORBIDITY; CONTROLLED STUDY; DRUG USE; EXFOLIATION SYNDROME; FEMALE; HEART DISEASE; HOSPITAL DEPARTMENT; HOSPITALIZATION; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NORWAY; OPEN ANGLE GLAUCOMA; PRIORITY JOURNAL; PROBABILITY; SENILE DEMENTIA; SURVIVAL;

ACETAZOLAMIDE; AGED; AGED, 80 AND OVER; CARBONIC ANHYDRASE INHIBITORS; CAUSE OF DEATH; CEREBROVASCULAR DISORDERS; COMORBIDITY; EXFOLIATION SYNDROME; FEMALE; GLAUCOMA, OPEN-ANGLE; HEART DISEASES; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; NORWAY; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 4444324641     PISSN: 13953907     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1395-3907.2004.00297.x     Document Type: Article

References (35)

1. Bayer AU & Ferrari (2002): Severe progression of glaucomatous optic neuropathy in patients with Alzheimer's disease. Eye 16: 209-212.
2. Bayer AU, Ferrari F & Erb C (2002): High occurrence rate of glaucoma among patients with Alzheimer's disease. Eur Neurol 47: 165-168.
3. Bayer AU, Keller ON, Ferrari F & Maag (2001): Association of glaucoma with neurodegenerative diseases with apoptotic cell death: Alzheimer's disease and Parkinson's disease. Am J Ophthalmol 133: 135-137.
4. Belloc NB (1963): Expectations of life for persons with glaucoma. J Chronic Dis 16: 163-171.
5. Dahl A, Russel D, Rootwelt K, Nyberg-Hansen R & Kerty E (1995): Cerebral vasoreactivity assessed with transcranial Doppler and regional cerebral blood flow measurements. Dose, serum concentration and time course of the response to acetazolamid. Stroke 26: 2302-2306.
6. Eagle RC Jr, Font RL & Fine BS (1979): The basement membrane syndrome. Arch Ophthalmol 97: 510-515.
7. Egge K & Zahl P-H (1999): Survival of glaucoma patients. Acta Ophthalmol Scand 77: 397-401.
8. Hagadus RJ, Wandel T, Ritch R, Scharf B & Kasten S (1989): Pseudoexfoliation in patients with Alzheimer's disease. Invest Ophthalmol Visual Sci 30: 27.
9. Harnisch J-P (1977): Exfoliation material in different sections of the eye. Graefes Arch Clin Exp Ophthalmol 203: 181-190.
10. Hiller R, Podgor MJ, Sperduto RD, Wilson PWF, Chew EY & D'Agostino RB (1999): High intraocular pressure and survival: the Framingham Studies. Am J Opthalmol 128: 440-445.
11. Janciauskiene S & Krakau T (2001): Alzheimer's peptide: a possible link between glaucoma, exfoliation syndrome and Alzheimer's disease. Acta Ophthalmol Scand 79: 238-239.
12. Kim TW, Kim DM & Park KH (2002): Neuroprotective effect of memantine in a rabbit model of optic nerve ischaemia. Korean J Ophthalmol 16: 1-7.
13. Konstas AGP, Tsatsos I, Kardasopoulos A, Bufidis T & Maskaleris G (1998): Preoperative features of patients with exfoliation glaucoma and primary open-angle glaucoma. The AHEPA Study. Acta Ophthalmol Scand 76: 208-212.
14. Layden WE & Schaffer RN (1974): Exfoliation syndrome. Am J Ophthalmol 78: 835-841.
15. Lee Di, Gómez-Marín O, Lam BL & Zheng DD (2003): Glaucoma and survival. The National Health Interview Survey 1986-94. Ophthalmology 110: 1476-1483.
16. Linnér E, Popovic V, Gottfries C-G, Jonsson M, Sjögren M & Wallin A (2001): The exfoliation syndrome in cognitive impairment of cerebrovascular or Alzheimer's type. Acta Ophthalmol Scand 79: 283-285.
17. McKinnon SJ (2003): Glaucoma: ocular Alzheimer's disease? Front Biosci 8: 1140 1156.
18. Mitchell P, Wang JJ & Smith W (1997): Association of pseudoexfoliation syndrome with increased vascular risk. Am J Ophthalmol 124: 685 687.
19. Repo LP, Suhonen MT, Teräsvirta ME & Koivisto KJ (1995): Colour Doppler imaging of the ophthalmic artery blood flow spectra of patients who have had a transient ischaemic attack. Ophthalmology 102: 1199 1205.
20. Ringvold A (1972): Electron microscopy of the limbal conjunctiva in eyes with pseudoexfoliation syndrome (PE syndrome). Virchows Arch Path Anat 355: 275 283.
21. Ringvold A (1973): On the occurrence of pseudoexfoliation material in extrabulbar tissue from patients with pseudoexfoliation syndrome of the eye. Acta Ophthalmol (Copenh) 51: 411 418.
22. Ringvold A, Blika S, Elsås T et al. (1991): The Middle-Norway Eye-screening Study. II. Prevalence of simple and capsular glaucoma. Acta Ophthalmol Scand 69: 273 280.
23. Ringvold A, Blika S & Sandvik L (1997): Pseudoexfoliation and mortality. Acta Ophthalmol Scand 75: 255 256.
24. Ringvold A & Øvergaard RG (1995): Increased IgA antibodies to gluten and gliadin in serum of persons with pseudoexfoliation syndrome. Acta Ophthalmol Scand 73: 171 172.
25. Ritch R, Schlötzer-Schrehardt U & Konstas AGP (2003): Why is glaucoma associated with exfoliation syndrome? Prog Retinal Eye Res 22: 253 275.
26. Schlötzer-Schrehardt U, Koca MR, Naumann GOH & Volkholz H (1992): Pseudoexfoliation syndrome. Ocular manifestation of a systemic disorder? Arch Ophthalmol 110: 1752 1759.
27. Schlötzer-Schrehardt U, Küchle M & Naumann GOH (1991): Electron-microscopic identification of pseudoexfoliation material in extrabulbar tissue. Arch Ophthalmol 109: 565 570.
28. Shingleton BJ, Heltzer J & O'Donoghue MW (2003): Outcome of phacoemulsification in patients with and without pseudoexfoliation syndrome. J Cataract Refract Surg 29: 1080 1086.
29. Shiogai T, Koshimura M, Murata Y et al. (2003): Acetazolamide vasoreactivity evaluated by transcranial harmonic perfusion imaging: relationship with transcranial Doppler sonography and dynamic CT. Acta Neurochir Suppl 86: 57 62.
30. Shrum KR, Hattenhauer MG & Hodge D (2000): Cardiovascular and cerebrovascular mortality associated with ocular pseudoexfoliation. Am J Ophthalmol 129: 83 86.
31. Streeten BW, Dark JA, Wallace RN, Li BSZ-Y & Hoepner JA (1990): Pseudoexfoliative fibrillopathy in the skin of patients with ocular pseudoexfoliation. Am J Ophthalmol 110: 490-499.
32. Streeten BW, Li Z-Y, Wallace RN, Eagle RC Jr & Keshgegian AA (1992): Pseudoexfoliative fibrillopathy in visceral organs of a patient with pseudoexfoliation syndrome. Arch Ophthalmol 110: 1757-1762.
33. Sugino T (1990): Exfoliative materials in the skin of patients with exfoliation syndrome. Acta Soc Ophthalmol Jpn 94: 856-869.
34. Thorburn W & Lindblom B (1983): Survival time among patients with glaucomatous visual field defects. Acta Ophthalmol (Copenh) 62: 728 730.
35. Waldmann E, Gasser P, Dubler B, Huber C & Flammer J (1996): Silent myocardial ischaemia in glaucoma and cataract patients. Graefes Arch Clin Exp Ophthalmol 234: 595-598.